Presenting: First Opinion: Mark Cuban
Tradeoffs
Unpacking Drug Pricing Complexity
This chapter explores the convoluted landscape of drug pricing in the U.S., focusing on the significant role of pharmacy benefit managers (PBMs) and their influence on medication costs. It discusses the need for transparency and suggests that alternative models like pass-through PBMs could improve pricing structures. The conversation also touches on the broader issues of patent manipulation and the challenges they pose to effective negotiation and affordability in the pharmaceutical market.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
